Literature DB >> 17332277

Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications.

Suyun Huang1.   

Abstract

Numerous cytokines, growth factors, and oncogenic proteins activate signal transducer and activator of transcription 3 (Stat3), which has been recognized as one of the common pathways in cancer cells. Stat3 signaling affects the expression and function of a variety of genes that are critical to cell survival, cell proliferation, invasion, angiogenesis, and immune evasion. Evidently, the Stat3 signaling pathway regulates cancer metastasis and constitutes a potential preventive and therapeutic target for cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332277     DOI: 10.1158/1078-0432.CCR-06-2313

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  102 in total

1.  Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase.

Authors:  Xueliang Gao; Haizhen Wang; Jenny J Yang; Xiaowei Liu; Zhi-Ren Liu
Journal:  Mol Cell       Date:  2012-02-02       Impact factor: 17.970

2.  Blockade of glioma proliferation through allosteric inhibition of JAK2.

Authors:  Kunyan He; Qi Qi; Chi-Bun Chan; Ge Xiao; Xia Liu; Carol Tucker-Burden; Liya Wang; Hui Mao; Xiang Lu; Frank E McDonald; Hongbo Luo; Qi-Wen Fan; William A Weiss; Shi-Yong Sun; Daniel J Brat; Keqiang Ye
Journal:  Sci Signal       Date:  2013-07-09       Impact factor: 8.192

3.  Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma.

Authors:  Giacomo Diaz; Ronald E Engle; Ashley Tice; Marta Melis; Stephanie Montenegro; Jaime Rodriguez-Canales; Jeffrey Hanson; Michael R Emmert-Buck; Kevin W Bock; Ian N Moore; Fausto Zamboni; Sugantha Govindarajan; David E Kleiner; Patrizia Farci
Journal:  Mol Cancer Res       Date:  2018-06-01       Impact factor: 5.852

4.  A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.

Authors:  Ling-Yuan Kong; Mohamed K Abou-Ghazal; Jun Wei; Arup Chakraborty; Wei Sun; Wei Qiao; Gregory N Fuller; Izabela Fokt; Elizabeth A Grimm; Robert J Schmittling; Gary E Archer; John H Sampson; Waldemar Priebe; Amy B Heimberger
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

Review 5.  Targeting SH2 domains in breast cancer.

Authors:  Pietro Morlacchi; Fredika M Robertson; Jim Klostergaard; John S McMurray
Journal:  Future Med Chem       Date:  2014       Impact factor: 3.808

6.  miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells.

Authors:  Nicola Amodio; Dina Bellizzi; Marzia Leotta; Lavinia Raimondi; Lavinia Biamonte; Patrizia D'Aquila; Maria Teresa Di Martino; Teresa Calimeri; Marco Rossi; Marta Lionetti; Emanuela Leone; Giuseppe Passarino; Antonino Neri; Antonio Giordano; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Cell Cycle       Date:  2013-09-25       Impact factor: 4.534

7.  Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway.

Authors:  Yutaka Takahashi; Michiko Takahashi; Nick Carpino; Shiann-Tarng Jou; Jyh-Rong Chao; Satoshi Tanaka; Yasufumi Shigeyoshi; Evan Parganas; James N Ihle
Journal:  Mol Endocrinol       Date:  2008-05-01

8.  Bortezomib enhances antigen-specific cytotoxic T cell responses against immune-resistant cancer cells generated by STAT3-ablated dendritic cells.

Authors:  Jee-Eun Kim; Dong-Hoon Jin; Wang Jae Lee; Daeyoung Hur; T-C Wu; Daejin Kim
Journal:  Pharmacol Res       Date:  2013-02-18       Impact factor: 7.658

Review 9.  The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells.

Authors:  Natalia Gawlik-Rzemieniewska; Ilona Bednarek
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

10.  Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.

Authors:  Hui-Wen Lo; Xinyu Cao; Hu Zhu; Francis Ali-Osman
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.